Rhythm Pharmaceuticals Shareholders Equity (Quarterly) Insights

Rhythm Pharmaceuticals Inc (RYTM)

52.98 +3.98 (+8.11%) USD | NASDAQ | Nov 04, 16:00

52.98 0.00 (0.00%) After-Hours: 20:00

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
June 30, 2024	179.50M
March 31, 2024	61.58M
December 31, 2023	169.76M
September 30, 2023	197.47M
June 30, 2023	182.28M
March 31, 2023	219.76M
December 31, 2022	264.26M
September 30, 2022	281.20M
June 30, 2022	195.63M
March 31, 2022	235.77M
December 31, 2021	284.15M
September 30, 2021	322.26M
June 30, 2021	351.69M
March 31, 2021	380.95M
December 31, 2020	166.53M

Date	Value
September 30, 2020	196.94M
June 30, 2020	225.75M
March 31, 2020	253.10M
December 31, 2019	281.02M
September 30, 2019	149.12M
June 30, 2019	181.47M
March 31, 2019	220.49M
December 31, 2018	246.26M
September 30, 2018	269.64M
June 30, 2018	284.32M
March 31, 2018	133.66M
December 31, 2017	144.79M
September 30, 2017	29.09M
June 30, 2017	35.77M
December 31, 2016	7.297M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

61.58M

Minimum

Mar 2024

380.95M

Maximum

Mar 2021

234.19M

Average

225.75M

Median

Jun 2020

Shareholders Equity (Quarterly) Benchmarks

Eli Lilly and Co	14.24B
TG Therapeutics Inc	177.57M
Regeneron Pharmaceuticals Inc	29.33B
Mirum Pharmaceuticals Inc	228.99M
Moderna Inc	11.71B

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly)	381.85M
Total Liabilities (Quarterly)	202.35M
Current Ratio	6.531